Clinical Trial Update: Comparative Evaluation of Albumin and Starch Effects in Acute Lung Injury (ALI) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing albumin to starch therapy in acute lung injury and acute respiratory distress syndrome was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury
• Respiratory Distress Syndrome

Drugs mentioned

• Albumin
• Hydroxyethyl starch (hydroxyethyl starch)

Snippet

Sponsor: Emory University | Conditions: Lung Injury, Acute (ALI), Respiratory Distress Syndrome, Acute (ARDS) | Phase 3 | Status: TERMINATED | Results posted: 2017-04-28